Results 131 to 140 of about 8,700 (159)

Cytosine methylation contributes to the fitness of <i>Caulobacter</i> cells naturally expressing a Vsr-like protein. [PDF]

iScience
Matthey N, Wennubst G, Pellaton N, Bojkowska K, Marquis J, Collier J.   +5 more
europepmc   +1 more source

Molecular pathogenesis in hereditary non-polyposis colorectal cancer (HNPCC) syndrome [PDF]

, 2004
Kariola, Reetta
core  

Denosumab combined with immunotherapy, radiotherapy, and granulocyte-macrophage colony-stimulating factor for the treatment of metastatic nasopharyngeal carcinoma: A case report. [PDF]

World J Clin Oncol
Chen WW, Kong YH, Zhang LY.
europepmc   +1 more source

The Efficacy of Pembrolizumab Immunotherapy in the Treatment of Endometrial Cancer: A Systematic Review. [PDF]

Int J Mol Sci
Picheta N, Piekarz J, Kułak K, Tarkowski R.   +3 more
europepmc   +1 more source

Disruption of protein-protein interaction hotspots in the C-terminal domain of MLH1 confers mismatch repair deficiency. [PDF]

NAR Cancer
Fishwick KM, Gomez Vieito D, Greco G, Collotta G, Gatti M, Kulik AA, Guérois R, Corbeski I, Phadte AS, Senoussi I, Cejka P, Pluciennik A, Porro A, Sartori AA.   +13 more
europepmc   +1 more source

Machine Learning-Based Pathomics Signature in Predicting MSH2 Expression and Prognosis in Gastric Cancer. [PDF]

Clin Transl Gastroenterol
Zhang ZR, Wang Y, Yan WW, Li HR, Cheng ZW, Han T, Zhang C, Wang XM.   +7 more
europepmc   +1 more source

Advances in Tissue-Agnostic Targeting in Cancer Therapeutics: Current Approvals, Challenges, and Future Directions. [PDF]

Oncol Res
Rubinstein M, Hong ML, Nanda RK, Jones DT, Aboaid H, Myat YM, Thein KZ.   +6 more
europepmc   +1 more source

Intrathoracic Rhabdoid Tumors Showing Rapid Progress in Patients with a History of Immune-suppressive Therapies for Hematological Diseases. [PDF]

Intern Med
Sasaki M, Imi T, Yoshida A.
europepmc   +1 more source

MGMT, NUPR1, NDRG2, and GLI1 Gene Promoter Methylation in Glioblastoma Tissues and Association with Clinical Characteristics and Therapeutic Outcomes. [PDF]

Int J Mol Sci
Gabr MM, AbdelHamid SG, Ezz El Arab LR, Swellam M, Hamdy NM.   +4 more
europepmc   +1 more source

Successful Identification and Treatment of Cancer of Unknown Primary Originating From Gastric Cancer Using Comprehensive Genomic Profiling and Immune Checkpoint Inhibitor Therapy: A Case Report. [PDF]

Cancer Rep (Hoboken)
Sasaki T, Yuzawa S, Tanabe H, Ono Y, Takahashi K, Ando K, Ueno N, Kashima S, Moriichi K, Tanino M, Mizukami Y, Fujiya M.   +11 more
europepmc   +1 more source